IBI333

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI333, covering 2024-09-04 to 2024-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study of IBI333 in Subjects With Neovascular Age-related Macular Degeneration [Phase 1]